Loading...
Loading...
Medikra Inc.
Medikra Inc.. Spoken Alpha tracks MDKR's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks MDKR's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for MDKR.
curl https://api.spokenalpha.com/v1/companies/MDKR| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $0.66 | $0.88 | -25.4% | +1.3% | +0.6% |
| Q4 FY2026 | $0.66 | $0.91 | -27.3% | -4.3% | -5.2% |
| Q3 FY2026 | $0.82 | $0.96 | -14.6% | +0.9% | +3.1% |
| Q2 FY2026 | $0.86 | $1.03 | -16.3% | +3.5% | +2.4% |
| Q1 FY2025 | $0.80 | $0.94 | -14.4% | -3.1% | -5.2% |
| Q4 FY2025 | $0.87 | $1.16 | -24.6% | -2.3% | +0.3% |
| Q3 FY2025 | $0.90 | $1.22 | -26.5% | -3.2% | -1.0% |
| Q2 FY2025 | $0.90 | $1.07 | -16.3% | +3.0% | +0.3% |
| Q1 FY2024 | $0.93 | $1.17 | -20.6% | +0.5% | +1.7% |
| Q4 FY2024 | $1.10 | $1.28 | -14.3% | -0.9% | +0.5% |